{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:39:33Z","timestamp":1795045173265,"version":"4.10.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Although advanced lipidomics technology facilitates quantitation of intracellular lipid components, little is known about the regulation of lipid metabolism in cancer cells. Here, we show that disruption of the\n                    <jats:italic>Gdpd3<\/jats:italic>\n                    gene encoding a lysophospholipase D enzyme significantly decreased self-renewal capacity in murine chronic myelogenous leukaemia (CML) stem cells in vivo. Sophisticated lipidomics analyses revealed that\n                    <jats:italic>Gdpd3<\/jats:italic>\n                    deficiency reduced levels of certain lysophosphatidic acids (LPAs) and lipid mediators in CML cells. Loss of\n                    <jats:italic>Gdpd3<\/jats:italic>\n                    also activated AKT\/mTORC1 signalling and cell cycle progression while suppressing Foxo3a\/\u03b2-catenin interaction within CML stem cell nuclei. Strikingly, CML stem cells carrying a hypomorphic mutation of\n                    <jats:italic>Lgr4\/Gpr48<\/jats:italic>\n                    , which encodes a leucine-rich repeat (LRR)-containing G-protein coupled receptor (GPCR) acting downstream of Gdpd3, displayed inadequate disease-initiating capacity in vivo. Our data showing that lysophospholipid metabolism is required for CML stem cell maintenance in vivo establish a new, biologically significant mechanism of cancer recurrence that is independent of oncogene addiction.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-18491-9","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T17:28:45Z","timestamp":1600363725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-6004","authenticated-orcid":false,"given":"Kazuhito","family":"Naka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2730-8457","authenticated-orcid":false,"given":"Ryosuke","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1580-6587","authenticated-orcid":false,"given":"Eriko","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-836X","authenticated-orcid":false,"given":"Chie","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2814-0887","authenticated-orcid":false,"given":"Kyung-Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5418-1981","authenticated-orcid":false,"given":"Takayuki","family":"Hoshii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3056-2499","authenticated-orcid":false,"given":"Masatake","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1396-1527","authenticated-orcid":false,"given":"Kimi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2856-1518","authenticated-orcid":false,"given":"Yusuke","family":"Sotomaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8521-9316","authenticated-orcid":false,"given":"Ko","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9736-9469","authenticated-orcid":false,"given":"Kinuko","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3967-4267","authenticated-orcid":false,"given":"Dong-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2637-1219","authenticated-orcid":false,"given":"Akira","family":"Ooshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4335-8793","authenticated-orcid":false,"given":"Seong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"18491_CR1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","volume":"9","author":"G van Meer","year":"2008","unstructured":"van Meer, G., Voelker, D. R. & Feigenson, G. W. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112\u2013124 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"18491_CR2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan, C. N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92\u2013101 (2014).","journal-title":"Nature"},{"key":"18491_CR3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig, F. & Schulze, A. The multifaceted roles of fatty acid synthesis in cancer. Nat. Rev. Cancer 16, 732\u2013749 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"18491_CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0021-9258(19)50785-2","volume":"222","author":"EP Kennedy","year":"1956","unstructured":"Kennedy, E. P. & Weiss, S. B. The function of cytidine coenzymes in the biosynthesis of phospholipides. J. Biol. Chem. 222, 193\u2013214 (1956).","journal-title":"J. Biol. Chem."},{"key":"18491_CR5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0021-9258(18)70453-5","volume":"231","author":"WE Lands","year":"1958","unstructured":"Lands, W. E. Metabolism of glycerolipides; a comparison of lecithin and triglyceride synthesis. J. Biol. Chem. 231, 883\u2013888 (1958).","journal-title":"J. Biol. Chem."},{"key":"18491_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.R800046200","volume":"284","author":"H Shindou","year":"2009","unstructured":"Shindou, H. & Shimizu, T. Acyl-CoA:lysophospholipid acyltransferases. J. Biol. Chem. 284, 1\u20135 (2009).","journal-title":"J. Biol. Chem."},{"key":"18491_CR7","doi-asserted-by":"crossref","first-page":"39436","DOI":"10.1074\/jbc.M205623200","volume":"277","author":"A Tokumura","year":"2002","unstructured":"Tokumura, A. et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277, 39436\u201339442 (2002).","journal-title":"J. Biol. Chem."},{"key":"18491_CR8","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1074\/jbc.M114.614537","volume":"290","author":"N Ohshima","year":"2015","unstructured":"Ohshima, N. et al. New members of the mammalian glycerophosphodiester phosphodiesterase family: GDE4 and GDE7 produce lysophosphatidic acid by lysophospholipase D activity. J. Biol. Chem. 290, 4260\u20134271 (2015).","journal-title":"J. Biol. Chem."},{"key":"18491_CR9","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.bbalip.2016.09.008","volume":"1861","author":"IA Rahman","year":"2016","unstructured":"Rahman, I. A. et al. Calcium-dependent generation of N-acylethanolamines and lysophosphatidic acids by glycerophosphodiesterase GDE7. Biochim. Biophys. Acta 1861, 1881\u20131892 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"18491_CR10","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","volume":"55","author":"YC Yung","year":"2014","unstructured":"Yung, Y. C., Stoddard, N. C. & Chun, J. LPA receptor signaling: pharmacology, physiology, and pathophysiology. J. Lipid Res. 55, 1192\u20131214 (2014).","journal-title":"J. Lipid Res."},{"key":"18491_CR11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2014.11.020","volume":"333","author":"Y Kihara","year":"2015","unstructured":"Kihara, Y., Mizuno, H. & Chun, J. Lysophospholipid receptors in drug discovery. Exp. Cell Res. 333, 171\u2013177 (2015).","journal-title":"Exp. Cell Res."},{"key":"18491_CR12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ccr.2009.03.027","volume":"15","author":"S Liu","year":"2009","unstructured":"Liu, S. et al. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 15, 539\u2013550 (2009).","journal-title":"Cancer Cell"},{"key":"18491_CR13","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrm3188","volume":"12","author":"WH Moolenaar","year":"2011","unstructured":"Moolenaar, W. H. & Perrakis, A. Insights into autotaxin: how to produce and present a lipid mediator. Nat. Rev. Mol. Cell Biol. 12, 674\u2013679 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"18491_CR14","doi-asserted-by":"crossref","DOI":"10.1038\/srep29935","volume":"6","author":"T Hiraide","year":"2016","unstructured":"Hiraide, T. et al. Accumulation of arachidonic acid-containing phosphatidylinositol at the outer edge of colorectal cancer. Sci. Rep. 6, 29935 (2016).","journal-title":"Sci. Rep."},{"key":"18491_CR15","doi-asserted-by":"crossref","first-page":"e0183724","DOI":"10.1371\/journal.pone.0183724","volume":"12","author":"Y Hosokawa","year":"2017","unstructured":"Hosokawa, Y. et al. Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues. PLoS ONE 12, e0183724 (2017).","journal-title":"PLoS ONE"},{"key":"18491_CR16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45506-3","volume":"9","author":"Y Muranishi","year":"2019","unstructured":"Muranishi, Y. et al. The ratios of monounsaturated to saturated phosphatidylcholines in lung adenocarcinoma microenvironment analyzed by liquid chromatography-mass spectrometry and imaging Mass spectrometry. Sci. Rep. 9, 8916 (2019).","journal-title":"Sci. Rep."},{"key":"18491_CR17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","volume":"12","author":"T O\u2019Hare","year":"2012","unstructured":"O\u2019Hare, T., Zabriskie, M. S., Eiring, A. M. & Deininger, M. W. Pushing the limits of targeted therapy in chronic myeloid leukaemia. Nat. Rev. Cancer 12, 513\u2013526 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"18491_CR18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin, A. S. et al. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J. Clin. Invest. 121, 396\u2013409 (2011).","journal-title":"J. Clin. Invest."},{"key":"18491_CR19","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2016.115","volume":"30","author":"S Sau\u00dfele","year":"2016","unstructured":"Sau\u00dfele, S., Richter, J., Hochhaus, A. & Mahon, F. X. The concept of treatment-free remission in chronic myeloid leukemia. Leukemia 30, 1638\u20131647 (2016).","journal-title":"Leukemia"},{"key":"18491_CR20","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","volume":"129","author":"TL Holyoake","year":"2017","unstructured":"Holyoake, T. L. & Vetrie, D. The chronic myeloid leukemia stem cell: stemming the tide of persistence. Blood 129, 1595\u20131606 (2017).","journal-title":"Blood"},{"key":"18491_CR21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature15248","volume":"525","author":"S Prost","year":"2015","unstructured":"Prost, S. et al. Erosion of the chronic myeloid leukaemia stem cell pool by PPAR\u03b3 agonists. Nature 525, 380\u2013383 (2015).","journal-title":"Nature"},{"key":"18491_CR22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y Chen","year":"2009","unstructured":"Chen, Y., Hu, Y., Zhang, H., Peng, C. & Li, S. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat. Genet. 41, 783\u2013792 (2009).","journal-title":"Nat. Genet."},{"key":"18491_CR23","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1172\/JCI66129","volume":"124","author":"Y Chen","year":"2014","unstructured":"Chen, Y. et al. Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival. J. Clin. Invest. 124, 3847\u20133862 (2014).","journal-title":"J. Clin. Invest."},{"key":"18491_CR24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.stem.2017.08.001","volume":"21","author":"F Li","year":"2017","unstructured":"Li, F. et al. Prostaglandin E1 and its analog Misoprostol inhibit human CML stem cell self-renewal via EP4 receptor activation and repression of AP-1. Cell Stem Cell 21, 359\u2013373 (2017).","journal-title":"Cell Stem Cell"},{"key":"18491_CR25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","volume":"463","author":"K Naka","year":"2010","unstructured":"Naka, K. et al. TGF-\u03b2-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463, 676\u2013680 (2010).","journal-title":"Nature"},{"key":"18491_CR26","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9039","volume":"6","author":"K Naka","year":"2015","unstructured":"Naka, K. et al. Dipeptide species regulate p38MAPK-Smad3 signalling to maintain chronic myelogenous leukaemia stem cells. Nat. Commun. 6, 8039 (2015).","journal-title":"Nat. Commun."},{"key":"18491_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/71691","volume":"24","author":"CS Huettner","year":"2000","unstructured":"Huettner, C. S., Zhang, P., Van Etten, R. A. & Tenen, D. G. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat. Genet. 24, 57\u201360 (2000).","journal-title":"Nat. Genet."},{"key":"18491_CR28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","volume":"105","author":"S Koschmieder","year":"2005","unstructured":"Koschmieder, S. et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood 105, 324\u2013334 (2005).","journal-title":"Blood"},{"key":"18491_CR29","doi-asserted-by":"crossref","first-page":"e00385","DOI":"10.1128\/MCB.00385-18","volume":"38","author":"R Wijayatunge","year":"2018","unstructured":"Wijayatunge, R. et al. Deficiency of the endocytic protein Hip1 leads to decreased Gdpd3 expression, low phosphocholine, and kypholordosis. Mol. Cell. Biol. 38, e00385\u201318 (2018).","journal-title":"Mol. Cell. Biol."},{"key":"18491_CR30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/leu.2008.337","volume":"23","author":"D Bruennert","year":"2009","unstructured":"Bruennert, D. et al. Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy. Leukemia 23, 983\u2013985 (2009).","journal-title":"Leukemia"},{"key":"18491_CR31","doi-asserted-by":"crossref","DOI":"10.1038\/srep11410","volume":"5","author":"H Igarashi","year":"2015","unstructured":"Igarashi, H., Akahoshi, N., Ohto-Nakanishi, T., Yasuda, D. & Ishii, S. The lysophosphatidic acid receptor LPA4 regulates hematopoiesis-supporting activity of bone marrow stromal cells. Sci. Rep. 5, 11410 (2015).","journal-title":"Sci. Rep."},{"key":"18491_CR32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nature07602","volume":"457","author":"N Barker","year":"2009","unstructured":"Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608\u2013611 (2009).","journal-title":"Nature"},{"key":"18491_CR33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"T Sato","year":"2009","unstructured":"Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262\u2013265 (2009).","journal-title":"Nature"},{"key":"18491_CR34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124\u20131134 (2017).","journal-title":"Nat. Med."},{"key":"18491_CR35","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1210\/me.2004-0133","volume":"18","author":"S Mazerbourg","year":"2004","unstructured":"Mazerbourg, S. et al. Leucine-rich repeat-containing, G protein-coupled receptor 4 null mice exhibit intrauterine growth retardation associated with embryonic and perinatal lethality. Mol. Endocrinol. 18, 2241\u20132254 (2004).","journal-title":"Mol. Endocrinol."},{"key":"18491_CR36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1095\/biolreprod.106.054619","volume":"76","author":"T Hoshii","year":"2007","unstructured":"Hoshii, T. et al. LGR4 regulates the postnatal development and integrity of male reproductive tracts in mice. Biol. Reprod. 76, 303\u2013313 (2007).","journal-title":"Biol. Reprod."},{"key":"18491_CR37","doi-asserted-by":"crossref","first-page":"11452","DOI":"10.1073\/pnas.1106083108","volume":"108","author":"KS Carmon","year":"2011","unstructured":"Carmon, K. S., Gong, X., Lin, Q., Thomas, A. & Liu, Q. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt\/\u03b2-catenin signaling. Proc. Natl Acad. Sci. USA 108, 11452\u201311457 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18491_CR38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature10337","volume":"476","author":"W de Lau","year":"2011","unstructured":"de Lau, W. et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476, 293\u2013297 (2011).","journal-title":"Nature"},{"key":"18491_CR39","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/embor.2011.175","volume":"12","author":"A Glinka","year":"2011","unstructured":"Glinka, A. et al. LGR4 and LGR5 are R-spondin receptors mediating Wnt\/\u03b2-catenin and Wnt\/PCP signalling. EMBO Rep. 12, 1055\u20131061 (2011).","journal-title":"EMBO Rep."},{"key":"18491_CR40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2012.02.017","volume":"10","author":"FH Heidel","year":"2012","unstructured":"Heidel, F. H. et al. Genetic and pharmacologic inhibition of \u03b2-catenin targets imatinib-resistant leukemia stem cells in CML. Cell Stem Cell 10, 412\u2013424 (2012).","journal-title":"Cell Stem Cell"},{"key":"18491_CR41","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.2772","volume":"18","author":"SP Tenbaum","year":"2012","unstructured":"Tenbaum, S. P. et al. \u03b2-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat. Med. 18, 892\u2013901 (2012).","journal-title":"Nat. Med."},{"key":"18491_CR42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature22070","volume":"545","author":"T Flock","year":"2017","unstructured":"Flock, T. et al. Selectivity determinants of GPCR-G-protein binding. Nature 545, 317\u2013322 (2017).","journal-title":"Nature"},{"key":"18491_CR43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cell.2017.11.033","volume":"172","author":"AS Hauser","year":"2018","unstructured":"Hauser, A. S. et al. Pharmacogenomics of GPCR Drug Targets. Cell 172, 41\u201354 e19 (2018).","journal-title":"Cell"},{"key":"18491_CR44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrd.2018.180","volume":"18","author":"I Shimada","year":"2019","unstructured":"Shimada, I., Ueda, T., Kofuku, Y., Eddy, M. T. & Wuthrich, K. GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures. Nat. Rev. Drug Discov. 18, 59\u201382 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"18491_CR45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-394587-7.00005-1","volume":"115","author":"VA Doze","year":"2013","unstructured":"Doze, V. A. & Perez, D. M. GPCRs in stem cell function. Prog. Mol. Biol. Transl. Sci. 115, 175\u2013216 (2013).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"18491_CR46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5483\/BMBRep.2015.48.2.250","volume":"48","author":"HY Choi","year":"2015","unstructured":"Choi, H. Y. et al. G protein-coupled receptors in stem cell maintenance and somatic reprogramming to pluripotent or cancer stem cells. BMB Rep. 48, 68\u201380 (2015).","journal-title":"BMB Rep."},{"key":"18491_CR47","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1182\/blood-2013-10-532523","volume":"124","author":"PA Dietrich","year":"2014","unstructured":"Dietrich, P. A. et al. GPR84 sustains aberrant \u03b2-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis. Blood 124, 3284\u20133294 (2014).","journal-title":"Blood"},{"key":"18491_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2016.07.017","volume":"418","author":"M Hashimoto","year":"2016","unstructured":"Hashimoto, M., Yamashita, Y. & Takemoto, T. Electroporation of Cas9 protein\/sgRNA into early pronuclear zygotes generates non-mosaic mutants in the mouse. Dev. Biol. 418, 1\u20139 (2016).","journal-title":"Dev. Biol."},{"key":"18491_CR49","first-page":"2579","volume":"9","author":"L van der Maaten","year":"2008","unstructured":"van der Maaten, L. & Hinton, G. Visualizing Data using t-SNE. J. Mach. Learn. Res. 9, 2579\u20132605 (2008).","journal-title":"J. Mach. Learn. Res."},{"key":"18491_CR50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jchromb.2015.05.015","volume":"995\u2013996","author":"M Yamada","year":"2015","unstructured":"Yamada, M. et al. A comprehensive quantification method for eicosanoids and related compounds by using liquid chromatography\/mass spectrometry with high speed continuous ionization polarity switching. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 995\u2013996, 74\u201384 (2015).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"18491_CR51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"18491_CR52","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"18491_CR53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc.: Ser. B (Methodol.) 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc.: Ser. B (Methodol.)"},{"key":"18491_CR54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccell.2020.05.014","volume":"38","author":"B Salik","year":"2020","unstructured":"Salik, B. et al. Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia. Cancer Cell 38, 263\u2013278.e6 (2020).","journal-title":"Cancer Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18491-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18491-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18491-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T22:17:16Z","timestamp":1723587436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18491-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["18491"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-18491-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"12 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: R.O., E.M. and C.K. are employees of Shimadzu Techno-research, Inc. S.-J.K. has personal financial interests as a shareholder in MedPacto Inc. All other authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4681"}}